Patient Education -Metformin hydrochloride PDF

Preview

Summary

Patient Education -Metformin hydrochloride...

Description

vSim for Nursing PATIENT EDUCATION WORKSHEET N AME OF MEDICATION, C LASSIFICATION AND INCLUDE PROTOTYPE MEDICATION: Metformin hydrochloride (Glucophage, Glucophage XR, Glumetza, Riomet) CLASSIFICATION: Antidiabetics

PROTOTYPE: Biguanides S AFE D OSE OR D OSE RANGE, S AFE R OUTE Adults: If using immediate-release tablets or oral solution, initially 500 mg PO b.i.d. given with morning and evening meals, or 850 mg PO once daily given with morning meal. Titrate immediate-release forms in increments of 500 mg weekly or 850 mg every other week to maximum dose of 2,550 mg PO daily in divided doses. Children ages 10 and older: 500 mg PO b.i.d. using the immediate-release formulation only. Increase dosage in increments of 500 mg weekly up to a maximum of 2,000 mg daily in divided doses. PURPOSE FOR TAKING THIS M EDICATION Decreases hepatic glucose production and intestinal absorption of glucose and improves insulin sensitivity (increases peripheral glucose uptake and use).

PATIENT EDUCATION WHILE T AKING THIS MEDICATION

vSim for Nursing 



    

Instruct patient about nature of diabetes and importance of following therapeutic regimen, adhering to specific diet, losing weight, getting exercise, following personal hygiene programs, and avoiding infection. Explain how and when to monitor glucose level. Teach evidence of low and high glucose levels. Explain emergency measures. Instruct patient to stop drug and immediately notify prescriber about unexplained hyperventilation, muscle pain, malaise, dizziness, light-headedness, unusual sleepiness, unexplained stomach pain, feeling of coldness, slow or irregular HR, or other nonspecific symptoms of early lactic acidosis Warn patient against excessive alcohol intake while taking drug. Advise patient not to cut, crush, or chew extended-release tablets; instruct patient to swallow them whole. Tell patient that inactive ingredients may be eliminated in the stool as a soft mass resembling the original tablet. Instruct patient to carry medical identification at all times. Tell patient to report all adverse reactions and that diarrhea, nausea, and upset stomach generally subside over time.

Lippincott advisor for education. (n.d.). Retrieved February 26, 2021, from https://advisoredu.lww.com/lna/document.do?bid=6&did=863699...